The 5-HT2C receptor agonist WAY-163909 decreases impulsivity in the 5-choice serial reaction time test

Behavioural Brain Research

Volumn 188, Issue 2, 2008, Pages 412-415

  Navarra, Rachel ^a   Comery, Thomas A ^a   Graf, Radka ^a   Rosenzweig Lipson, Sharon ^a   Day, Mark ^b  

^a Discovery Neuroscience   (United States)

^b PFIZER INC   (United States)

Author keywords

5 Choice serial reaction time test; 5 HT2C; Impulsivity

Indexed keywords

1,2,3,4,8,9,10,10A OCTAHYDRO 7BH CYCLOPENTA[B][1,4]DIAZEPINO[6,7,1 HI]INDOLE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG; WAY 163909;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOSE RESPONSE; IMPULSIVENESS; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RESPONSE TIME;

ANIMALS; AZEPINES; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; IMPULSIVE BEHAVIOR; INDOLES; MALE; RATS; RATS, LONG-EVANS; REACTION TIME; RECEPTOR, SEROTONIN, 5-HT2C;

EID: 39149139621     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.11.016     Document Type: Article

References (15)

1. Winstanley C.A., Theobald D.E., Dalley J.W., Glennon J.C., and Robbins T.W. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) 176 (2004) 376-385
2. Moeller F.G., Barratt E.S., Dougherty D.M., Schmitz J.M., and Swann A.C. Psychiatric aspects of impulsivity. Am J Psychiatry 158 (2001) 1783-1793
3. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163 (2002) 362-380
4. Higgins G.A., Enderlin M., Haman M., and Fletcher P.J. The 5-HT2A receptor antagonist M100, 907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism. Psychopharmacology (Berl) 170 (2003) 309-319
5. Dunlop J., Marquis K.L., Lim H.K., Leung L., Kao J., Cheesman C., et al. Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications. CNS Drug Rev 12 (2006) 167-177
6. Marquis K.L., Sabb A.L., Logue S.F., Brennan J.A., Piesla M.J., Comery T.A., et al. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 320 (2007) 486-496
7. Day M., Pan J.B., Buckley M.J., Cronin E., Hollingsworth P.R., Hirst W.D., et al. Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test. Biochem Pharmacol 73 (2007) 1123-1134
8. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, et al. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry; 2007.
9. Cardinal R.N., Pennicott D.R., Sugathapala C.L., Robbins T.W., and Everitt B.J. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292 (2001) 2499-2501
10. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315 (2007) 1267-1270
11. Cole B.J., and Robbins T.W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33 (1989) 165-179
12. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, et al. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology; 2007.
13. Chamberlain S.R., Del Campo N., Dowson J., Muller U., Clark L., Robbins T.W., et al. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 62 (2007) 977-984
14. Gut-Fayand A., Dervaux A., Olie J.P., Loo H., Poirier M.F., and Krebs M.O. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res 102 (2001) 65-72
15. Rosenzweig-Lipson S., Sabb A., Stack G., Mitchell P., Lucki I., Malberg J.E., et al. Antidepressant-like effects of the novel, selective 5-HT2C receptor agonist WAY-163909 in rodents. Psychopharmacology (Berl) 192 (2007) 159-170